GLP-1 Withdrawal: If you stop the medication abruptly, the artificial satiety signal vanishes overnight
I share this in the hope that it helps any clinician struggling with the very difficult issues associated with FQ toxicity
Some research studies also used higher concentrations (up to 10%) while this ingredient is usually found in concentrations up to 0.005% in leave-on formulations
Available from: Carlsson AC, Wndell P, sby U, Zarrinkoub R, Wettermark B, Ljunggren G (2013) High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden - a challenge for public health
This is a different approach entirely, combining a GLP-1 agonist with an amylin receptor agonist rather than adding GIP or glucagon
Where do you take your cut on your overexpenditure